Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: Dysregulation of cytokine, chemokine, and Toll-like receptor 2 and 4 gene expression

Journal of Immunology

Volumn 164, Issue 11, 2000, Pages 5564-5574

  Medvedev, Andrei E ^a   Kopydlowski, Karen M ^a   Vogel, Stefanie N ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; ENDOTOXIN; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE; RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0034043956     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.11.5564     Document Type: Article

References (76)

1. Morrison, D. C., and J. L. Ryan. 1987. Endotoxins and disease mechanisms. Annu. Rev. Med. 38:417.
2. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431.
3. Wright, S. D., R. A. Ramos, A. Hermanowski-Vosatka, P. Rockwell, and P. A. Detmers. 1991. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J. Exp. Med. 173:1281.
4. Anderson, K. V., L. Bokla, and C. Nusslein-Volhard. 1985. Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product. Cell 42:791.
5. Lemaitre, B., E. Nicolas, L. Michaut, J. M. Reichhart, and J. A. Hoffmann. 1996. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973.
6. Rock, F. L., G. Hardiman, J. C. Timans, R. A. Kastelein, and J. F. Bazan. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 95:588.
7. Medzhitov, R., P. Preston-Hurlburt, and C. A. Janeway, Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394.
8. Chaudhary, P. M., C. Ferguson, V. Nguyen, O. Nguyen, H. F. Massa, M. Eby, A. Jasmin, B. J. Trask, L. Hood, and P. S. Nelson. 1998. Cloning and characterization of two Toll/interleukin-1 receptor-like genes TIL3 and TIL4: evidence for a miltigene receptor family in humans. Blood 91:4020.
9. Takeuchi, O., T. Kawai, H. Sanjo, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, K. Takeda, and S. Akira. 1999. TLR6: a novel member of an expanding Toll-like receptor family. Gene 231:59.
10. Poltorak, A., X. He, I. Smirnova, M.-Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in the tlr4 gene. Science 282:2085.
11. Qureshi, S. T., L. Lariviere, G. Leveque, S. Clermont, K. J. Moore, P. Gros, and D. Malo. 1999. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189:615.
12. n gene: in vivo evidence for a dominant negative mutation. J. Immunol. 162:5666.
13. Du, X., A. Poltorak, M. Silva, and B. Beutler. 1999. Analysis of Tlr4-mediated LPS signal transduction in macrophages by mutational modification of the receptor. Blood Cells Mol. Dis. 25:328.
14. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749.
15. Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, and M. Kimoto. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189:1777.
16. Yang, R.-B., M. R. Mark, A. Gray, A. Huang, M. H. Xie, M. Zhang, A. Goddard, W. I. Wood, A. L. Gurney, and P. J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395:284.
17. Kirschning, C., H. Wesche, T. M. Ayres, and M. Rothe. 1988. Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. Med. 188:2091.
18. Yang, R. B., M. R. Mark, A. L. Gurney, and P. J. Godowski. 1999. Signaling evenls induced by lipopolysaccharide-activated Toll-like receptor 2. J. Immunol. 163:639.
19. Zhang, F. X., C. J. Kirschning, R. Mancinelli, X.-P. Xu, Y. Jin, E. Faure, A. Mantovani, M. Rothe, M. Muzio, and M. Arditi. 1999. Bacterial lipopolysaccharide activates nuclear factor-κB through interleukin-1 signaling medialors in cultured human dermal endothelial cells and mononuclear phagocytes. J. Biol. Chem. 274:7611.
20. Brightbill, H. D., D. H. Library, S. R. Krutzik, R.-B. Yang, J. T. Belisle, J. R. Bleharski, M. Maitland, M. V. Norgard, S. E. Plevy, S. T. Smale, et al. 1999. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 285:732.
21. Aliprantis, A. O., R.-B. Yang, M. R. Mark, S. Suggett, B. Devaux, J. D. Radolf, G. R. Klimpel, P. Godowski, and A. Zychlinsky. 1999. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285:736.
22. Hirschfeld, M., C.J. Kirschning, R. Schwandner, H. Wesche, J. H. Weis, R. M. Wooten, and J. J. Weis. 1999. Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2. J. Immunol. 163:2382.
23. Yoshimura, A., E. Lien, R. R. Ingalls, E. Tuomanen, R. Dziarski, and D. T. Golenbock. 1999. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163:1.
24. Schwandler, R., R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274:17406.
25. Lien, E., T. J. Sellati, A. Yoshimura, T. H. Flo, G. Rawadi, R. W. Finberg, J. D. Carroll, T. Espevik, R. R. Ingalls, J. D. Radolf, and D. T. Golenbock. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274:33419.
26. Underhill, D. M., A. Ozinsky, A. M. Hajjar, A, Stevens, C. B. Wilson, M. Bassetti, and A. Aderem. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401:811.
27. Means, T. K., S. Wang, E. Lien, A. Yoshimura, D. T. Golenbock, and M. J. Fenton. 1999. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 163:3920.
28. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11:443.
29. Karp, C. L., M. Wysocka, X. Ma, M. Marovich, R. E. Factor, T. Nutman, M. Armant, L. Wahl, P. Cuomo, and G. Trinchieri. 1998. Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance. Eur. J. Immunol. 28:3128.
30. Schade, F. U., R. Flash, S. Flohe, M. Majetschak, E. Kreuzfelder, E. Dominguez-Fernandez, J. Borgermann, M. Reuter, and U. Obertacke. 1999. Endotoxin tolerance. In Endotoxin in Health and Disease. H. Brade, S. M. Opal, S. N. Vogel, and D. C. Morrison, eds. Marcel Dekker, New York, p. 50.
31. Shnyra, A., R. Brewington, A. Alipio, C. Amura, and D. C. Morrison. 1998. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12. J. Immunol. 160:3729.
32. Labeta, M. O., J. J. Durieux, G. Spagnoli, N. Fernandez, J. Wijdenes, and R. Hermann. 1993. CD14 and tolerance to lipopolysaccharide: biochemical and functional analysis. Immunology 80:415.
33. Makhlouf, M., B. Zingarelli, P. V. Halushka, and J. A. Cook. 1998. Endotoxin tolerance alters macrophage membrane regulatory G proteins. Prog. Clin. Biol. Res. 397:217.
34. Bowling, W. M., D. G. Hafenrichter, M. W. Flye, and M. P. Callery. 1995. Endotoxin tolerance alters phospholipase C-γ1 and phosphatidylinositol-3′-kinase expression in peritoneal macrophages. J. Surg. Res. 58:592.
35. Kraatz, J., L. Clair, J. L. Rodriguez, and M. A. West. 1999. In vitro macrophage endotoxin tolerance: defective in vitro macrophage MAP kinase signal transduction after LPS pretreatment is not present in macrophages from C3H/HeJ endotoxin resistant mice. Shock 11:58.
36. Kraatz, J., L. Clair, J. L. Rodriguez, and M. A. West. 1999. Macrophage TNF secretion in endotoxin tolerance: role of SAPK, p38, and MAPK. J. Surg. Res. 83:158.
37. Tominaga, K., S. Saito, M. Matsuura, and M. Nakano. 1999. Lipopolysaccharide tolerance in murine peritoneal macrophages induces down-regulation of the lipopolysaccharide signal transduction pathway through mitogen-activated protein kinase and nuclear factor-κB cascades, but not lipopolysaccharide-incorporation steps. Biochim. Biophys. Acta 1450:130.
38. Kohler, N. G., and A. Joly. 1997. The involvement of an LPS inducible IκB kinase in endotoxin tolerance. Biochem. Biophys. Res. Commun. 232:602.
39. Wahlstrom, K., J. Bellingham, J. L. Rodriguez, and M. A. West. 1999. Inhibitory κBα control of nuclear factor-κB is dysregulated in endotoxin tolerant macrophages. Shock 11:242.
40. Ziegler-Heitbrock, H. W. 1995. Molecular mechanism of tolerance to lipopolysaccharide. J. Inflamm. 45:13.
41. Yoza, B. K., J. D. Wells, and C. E. McCall. 1998. Interleukin-1β expression after inbibition of protein phosphatases in endotoxin-tolerant cells. Clin. Diagn. Lab. Immunol. 5:281.
42. Zuckerman, S. H., and G. F. Evans. 1992. Endotoxin tolerance: in vivo regulation of tumor necrosis factor and interleukin-1 synthesis is at the transcriptional level. Cell. Immunol. 140:513.
43. Shames, B. D., D. R. Meldrum, C. H. Selzman, E. J. Pulido, B. S. Cain, A. Banerjee, A. H. Harken, and X. Meng. 1998. Increased levels of myocardial IκB-α protein promote tolerance to endotoxin. Am. J. Physiol. 275:H1084.
44. Kravchenko, V. V., S. Steinemann, L. Kline, L. Feng, and R. J. Ulevitch. 1996. Endotoxin tolerance is induced in Chinese hamster ovary cell lines expressing human CD14. Shock 5:194.
45. Ziegler-Heitbrock, H. W., I. Petersmann, and M. Frankenberger. 1997. p50 (NF-κB1) is up-regulated in LPS tolerant P388D1 murine macrophages. Immunobiology 198:73.
46. Kastenbauer, S., and H. W. Ziegler-Heitbrock. 1999. NF-κB1 (p50) is up-regulated in lipopolysaccharide tolerance and can block tumor necrosis factor gene expression. Infect. Immun. 67:1553.
47. Ziegler-Heitbrock, H. W., A. Wedel, W. Schraut, M. Strobel, P. Wendelgass, T. Sternsdorf, P. A. Bauerle, J. G. Haas, and G. Riethmuller. 1994. Tolerance to lipopolysaccharide involves mobilization of nuclear factor κB with predominance of p50 homodimer. J. Biol. Chem. 269:17001.
48. Takasuka, N., K. Matsuura, S. Yamamoto, and K. S. Akagawa. 1995. Suppression of TNF-α mRNA expression in LPS-primed macrophages occurs at the level of nuclear factor-κB activation, but not at the level of protein kinase C or CD14 expression. J. Immunol. 154:4803.
49. Fujihara, M., K. Ikebuchi, T. L. Maekawa, S. Wakamoto, T. Ito, T. Suzuki, T. A. Takahashi, and S. Sekiguchi. 1998. Lipopolysaccharide-induced desensitization of junB gene expression in a mouse macrophage-like cell line, P388D1. J. Immunol. 161:3659.
50. Henricson, B. E., R. Neta, and S. N. Vogel. 1991. An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance. Infect. Immun. 59:1188.
51. Leon, P., H. P. Redmond, J. Shou, and J. M. Daly. 1992. Interleukin 1 and its relationship to endotoxin tolerance. Arch. Surg. 127:146.
52. 2. Blood 91:3112.
53. Ogle, C. K., X. Guo, W. T. Chance, and J. D. Ogle. 1997. Induction of endotoxin tolerance in rat bone marrow cells by in vivo infusion of tumor necrosis factor. Crit. Care Med. 25:827.
54. Li, M. H., S. C. Seatter, R. Manthei, M. Bubrick, and M. A. West. 1994. Macrophage endotoxin tolerance: effect of TNF or endotoxin pretreatment. J. Surg. Res. 57:85.
55. Erroi, A., G. Fantuzzi, M. Mengozzi, M. Sironi, S. F. Orencole, B. D. Clark, C. A. Dinarello, A. Isetta, P. Gnocchi, M. Giovarelli, et al. 1993. Differential regulation of cytokine production in lipopolysaccharide tolerance in mice. Infect. Immun. 61:4356.
56. McIntire, F. C., H. W. Sievert, G. H. Barlow, R. A. Finley, and A. Y. Lee. 1967. Chemical, physical, and biological properties of a lipopolysaccharide from Escherichia coli K235. Biochemistry 6:2363.
57. Medvedev, A. E., J. C. G. Blanco, N. Qureshi, and S. N. Vogel. 1999. Limited role of ceramide in lipopolysaccharide-mediated mitogen-activated protein kinase activation, transcription factor induction, and cytokine release. J. Biol. Chem. 274:9342.
58. Haas, M., S. Page, M. Page, F.-J. Neumann, N. Marx, M. Adam, H. W. L. Ziegler-Heitbrock, D. Neumeier, and K. Brand. 1998. Effect of proteasome inhibitors on monocytic IκB-α and -β depletion, NF-κB activation, and cytokine production. J. Leukocyte Biol. 63:395.
59. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475.
60. Manthey, C. L., N. Qureshi, P. L. Stutz, and S. N, Vogel. 1993. Lipopolysaccharide antagonists block taxol-induced signaling in murine macrophages. J. Exp. Med. 178:695.
61. Kopydlowski, K. M., C. A. Salkowski, M. J. Cody, N. van Rooijen, J. Major, T. A. Hamilton, and S. N. Vogel. 1999. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J. Immunol. 163:1537.
62. DeFranco, A. L., M. T. Crowley, A. Finn, J. Hambleton, and S. L. Weinstein. 1998. The role of tyrosine kinases and MAP kinases in LPS-induced signaling. Prog. Clin. Biol. Res. 397:119.
63. Payne, D. M., A. J. Rossomando, P. Martino, A. K. Erickson, J. H. Her, J. Shabanowitz, D. F. Hunt, M. J. Weber, and T. W. Sturgill. 1991. Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J. 10:885.
64. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-κB and Rel proteins: evolutionary conserved mediators of immune responses. Annu. Rev. Immunol. 16:225.
65. Salkowski, C. A., G. Detore, A. Franks, M. C. Falk, and S. N. Vogel. 1998. Pulmonary and hepatic gene expression following cecal ligation and puncture: monophosphoryl lipid A prophylaxis attenuates sepsis-induced cytokine and chemokine expression and neutrophil infiltration. Infect. Immun. 66:3569.
66. Henricson, B. E., C. L. Manthey, P. Y. Perera, T. A. Hamilton, and S. N. Vogel. 1993. Dissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryl lipid A. Infect. Immun. 61:2325.
67. Lakics, V., and S. N. Vogel. 1998. Lipopolysaccharide and ceramide use divergent signaling pathways to induce cell death in murine macrophages. J. Immunol. 161:2490.
68. Karin, M., Z. Liu, and E. Zandi. 1997. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:240.
69. Bohuslav, J., V. V. Kravchenko, G. C. Parry, J. H. Erlich, S. Gerondakis, N. Mackman, and R. J. Ulevitch. 1998. Regulation of an essential innate immune response by the p50 subunit of NF-κB. J. Clin. Invest. 102:1645.
70. Basu, S., A. R. Dunn, M. W. Marino, H. Savoia, G. Hodgson, G. J. Lieschke, and J. Cebon. 1997. Increased tolerance to endotoxin by granulocyte-macrophage colony-stimulating factor-deficient mice. J. Immunol. 159:1412.
71. Carter, A. B., K. L. Knudtson, M. M. Monick, and G. W. Hunninghake. 1999. The p38 mitogen-activated protein kinase is required for NF-κB-dependent gene expression. J. Biol. Chem. 274:30858.
72. Means, T. K., E. Lien, A. Yoshimura, S. Wang, D. T. Golenbock, and M. J. Fenton. 1999. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J. Immunol. 163:6748.
73. Frantz, S., L. Kobzik, Y. D. Kim, R. Fukazawa, R. Medzhitov, R. T. Lee, and R. A. Kelly. 1999. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J. Clin. Invest. 104:271.
74. Medzhitov, R., P. Preston-Hurlburt, E. Kopp, A. Stadlen, C. Chen, S. Ghosh, and C. A. Janeway, Jr. 1998. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 2:253.
75. O'Neill, L. A., and C. Greene. 1998. Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J. Leukocyte Biol. 63:650.
76. Wallach, D., E. E. Varfolomeev, N. L. Malinin, Y. V. Goltsev, A. V. Kovalenko, and M. P. Boldin. 1999. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17:331.